Americas,
May 2024
PharmaBoardroom’s latest report, InFigures: Latin America 2024 features up-to-date datasets from the region’s leading pharma markets and regional production hubs.
The combined Latin America and Caribbean market of USD 197 billion looks set to be the fastest growing in the world over the next few years. IQVIA estimates that the Latin American pharma market will expand at a stunning compound annual growth rate of 22 percent up to 2027, well above the global average of 7.8 percent, the Pharmerging market average of 7.1 percent, and the major developed market average of 7.0 percent.
Covering everything from macroeconomy to population health, market growth, company rankings, innovation footprints, production capacity, and export markets, this exclusive new report is an excellent jumping-off point for those looking to learn more about this dynamic region.
PharmaBoardroom’s latest report, InFigures: Latin America 2024 features up-to-date datasets from the region’s leading pharma markets and regional production hubs.
The combined Latin America and Caribbean market of USD 197 billion looks set to be the fastest growing in the world over the next few years. IQVIA estimates that the Latin American pharma market will expand at a stunning compound annual growth rate of 22 percent up to 2027, well above the global average of 7.8 percent, the Pharmerging market average of 7.1 percent, and the major developed market average of 7.0 percent.
Covering everything from macroeconomy to population health, market growth, company rankings, innovation footprints, production capacity, and export markets, this exclusive new report is an excellent jumping-off point for those looking to learn more about this dynamic region.
